Indications for autologous HSCT in Europe 1990-2000
| . | No. of patients . | |||
|---|---|---|---|---|
| Total 1990-2000 . | % . | Total 2000 . | % . | |
| Leukemias | 15 052 | 17.0 | 1 764 | 13.9 |
| Acute myeloid leukemia | 8 129 | 9.2 | 1 047 | 8.2 |
| Acute lymphocytic leukemia | 3 765 | 4.2 | 302 | 2.4 |
| Chronic myeloid leukemia | 1 967 | 2.2 | 148 | 1.2 |
| Myelodysplastic syndromes | 297 | 0.3 | 50 | 0.4 |
| Chronic lymphocytic leukemia | 894 | 1.0 | 217 | 1.7 |
| Lymphoproliferative disorders | 48 917 | 55.1 | 8 498 | 66.7 |
| Multiple myeloma | 16 206 | 18.3 | 3 388 | 26.6 |
| Hodgkin disease | 9 078 | 10.2 | 1 226 | 9.6 |
| Non-Hodgkin lymphoma | 23 633 | 26.6 | 3 884 | 30.5 |
| Solid tumors | 24 016 | 27.0 | 2 286 | 18.0 |
| Neuroblastoma | 1 912 | 2.2 | 262 | 2.1 |
| Glioma | 544 | 0.6 | 73 | 0.6 |
| Soft tissue sarcoma | 1 013 | 1.1 | 144 | 1.1 |
| Germinal tumors | 2 658 | 3.0 | 304 | 2.4 |
| Breast cancer | 12 598 | 14.2 | 781 | 6.1 |
| Ewing sarcoma | 1 401 | 1.6 | 244 | 1.9 |
| Lung cancer | 318 | 0.4 | 62 | 0.5 |
| Ovarian cancer | 628 | 0.7 | 100 | 0.8 |
| Other solid tumors | 2 944 | 3.3 | 316 | 2.5 |
| Nonmalignant disorders | 321 | 0.4 | 100 | 0.8 |
| Aplastic anemia + Fanconi | 7 | 0.0 | 1 | 0.0 |
| Thalassemia | 0 | 0.0 | 0 | 0.0 |
| Combined immune deficiencies | 10 | 0.0 | 2 | 0.0 |
| Inborn errors | 4 | 0.0 | 0 | 0.0 |
| Autoimmune diseases | 300 | 0.3 | 97 | 0.8 |
| Others | 492 | 0.6 | 84 | 0.7 |
| Total | 88 798 | 12 732 | ||
| . | No. of patients . | |||
|---|---|---|---|---|
| Total 1990-2000 . | % . | Total 2000 . | % . | |
| Leukemias | 15 052 | 17.0 | 1 764 | 13.9 |
| Acute myeloid leukemia | 8 129 | 9.2 | 1 047 | 8.2 |
| Acute lymphocytic leukemia | 3 765 | 4.2 | 302 | 2.4 |
| Chronic myeloid leukemia | 1 967 | 2.2 | 148 | 1.2 |
| Myelodysplastic syndromes | 297 | 0.3 | 50 | 0.4 |
| Chronic lymphocytic leukemia | 894 | 1.0 | 217 | 1.7 |
| Lymphoproliferative disorders | 48 917 | 55.1 | 8 498 | 66.7 |
| Multiple myeloma | 16 206 | 18.3 | 3 388 | 26.6 |
| Hodgkin disease | 9 078 | 10.2 | 1 226 | 9.6 |
| Non-Hodgkin lymphoma | 23 633 | 26.6 | 3 884 | 30.5 |
| Solid tumors | 24 016 | 27.0 | 2 286 | 18.0 |
| Neuroblastoma | 1 912 | 2.2 | 262 | 2.1 |
| Glioma | 544 | 0.6 | 73 | 0.6 |
| Soft tissue sarcoma | 1 013 | 1.1 | 144 | 1.1 |
| Germinal tumors | 2 658 | 3.0 | 304 | 2.4 |
| Breast cancer | 12 598 | 14.2 | 781 | 6.1 |
| Ewing sarcoma | 1 401 | 1.6 | 244 | 1.9 |
| Lung cancer | 318 | 0.4 | 62 | 0.5 |
| Ovarian cancer | 628 | 0.7 | 100 | 0.8 |
| Other solid tumors | 2 944 | 3.3 | 316 | 2.5 |
| Nonmalignant disorders | 321 | 0.4 | 100 | 0.8 |
| Aplastic anemia + Fanconi | 7 | 0.0 | 1 | 0.0 |
| Thalassemia | 0 | 0.0 | 0 | 0.0 |
| Combined immune deficiencies | 10 | 0.0 | 2 | 0.0 |
| Inborn errors | 4 | 0.0 | 0 | 0.0 |
| Autoimmune diseases | 300 | 0.3 | 97 | 0.8 |
| Others | 492 | 0.6 | 84 | 0.7 |
| Total | 88 798 | 12 732 | ||